Janux Therapeutics (NASDAQ:JANX) Coverage Initiated at Wolfe Research

Sports

3 overseas wicket-keeper batters KKR must target in IPL 2026 Auction ft. Jonny Bairstow

Published On : 2025-11-20

The Kolkata Knight Riders (KKR) have the biggest budget ahead of the IPL 2026 auction. After releasing 10 players, they are looking for an overhaul.

#Sports

Business

At Close of Business podcast November 20 2025

Published On : 2025-11-20

Mark Beyer and Justin Fris discuss WA’s contractor industry.

#Business

Business

Australia’s top-dollar homes: The priciest properties sold in every suburb – realestate.com.au

Published On : 2025-11-20

Australia’s top-dollar homes: The priciest properties sold in every suburb realestate.com.auView Full coverage on Google News

#Business

General

B. Riley Issues Pessimistic Forecast for BitFuFu (NASDAQ:FUFU) Stock Price

Published On : 2025-11-20

BitFuFu (NASDAQ:FUFU – Get Free Report) had its price objective dropped by equities researchers at B. Riley from $7.00 to $6.00 in a research note issued on Tuesday,Benzinga reports. The firm currently has a “buy” rating on the stock. B. Riley’s price objective would indicate a potential upside of 107.61% from the company’s previous close. […]

#General

General

Bank of America Has Lowered Expectations for Werewolf Therapeutics (NASDAQ:HOWL) Stock Price

Published On : 2025-11-20

Werewolf Therapeutics (NASDAQ:HOWL – Get Free Report) had its price objective dropped by equities research analysts at Bank of America from $8.00 to $7.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. A number of other research analysts have also recently […]

#General

General

Cantor Fitzgerald Begins Coverage on FormFactor (NASDAQ:FORM)

Published On : 2025-11-20

Stock analysts at Cantor Fitzgerald initiated coverage on shares of FormFactor (NASDAQ:FORM – Get Free Report) in a research note issued on Tuesday, MarketBeat reports. The brokerage set an “overweight” rating and a $75.00 price target on the semiconductor company’s stock. Cantor Fitzgerald’s price objective points to a potential upside of 48.75% from the company’s […]

#General

General

Citigroup Forecasts Strong Price Appreciation for National Vision (NASDAQ:EYE) Stock

Published On : 2025-11-20

National Vision (NASDAQ:EYE – Get Free Report) had its price objective hoisted by research analysts at Citigroup from $29.00 to $35.00 in a report issued on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Citigroup’s target price would indicate a potential upside of 41.59% from the stock’s previous close. Other equities […]

#General

General

D. Boral Capital Reaffirms “Hold” Rating for CERo Therapeutics (NASDAQ:CERO)

Published On : 2025-11-20

CERo Therapeutics (NASDAQ:CERO – Get Free Report)‘s stock had its “hold” rating reaffirmed by equities research analysts at D. Boral Capital in a research report issued to clients and investors on Tuesday,Benzinga reports. Other research analysts have also recently issued reports about the stock. Maxim Group cut shares of CERo Therapeutics from a “buy” rating […]

#General

General

Daiwa Capital Markets Issues Pessimistic Forecast for Comcast (NASDAQ:CMCSA) Stock Price

Published On : 2025-11-20

Comcast (NASDAQ:CMCSA – Get Free Report) had its price objective reduced by research analysts at Daiwa Capital Markets from $38.00 to $30.00 in a research note issued on Tuesday,MarketScreener reports. The brokerage currently has an “outperform” rating on the cable giant’s stock. Daiwa Capital Markets’ price target would indicate a potential upside of 11.65% from […]

#General

General

Divya Bharathi Takes Offense, Slams Director Naresh Kuppili over ‘Chilaka’

Published On : 2025-11-20

The controversy escalated after Divya shared a screenshot of a tweet in which Kuppili referred to her as “chilaka” and claimed she was suited only for a second-lead role.

#General

General

Evercore ISI Reiterates “Outperform” Rating for Intuit (NASDAQ:INTU)

Published On : 2025-11-20

Intuit (NASDAQ:INTU – Get Free Report)‘s stock had its “outperform” rating reiterated by equities researchers at Evercore ISI in a research report issued on Tuesday,Benzinga reports. They presently have a $875.00 price target on the software maker’s stock. Evercore ISI’s target price points to a potential upside of 34.49% from the stock’s current price. A […]

#General

General

Guggenheim Forecasts Strong Price Appreciation for Centessa Pharmaceuticals (NASDAQ:CNTA) Stock

Published On : 2025-11-20

Centessa Pharmaceuticals (NASDAQ:CNTA – Get Free Report) had its price objective increased by equities research analysts at Guggenheim from $28.00 to $43.00 in a research note issued to investors on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Guggenheim’s target price would suggest a potential upside of 53.57% from the company’s […]

#General

General

Guggenheim Has Lowered Expectations for Eledon Pharmaceuticals (NASDAQ:ELDN) Stock Price

Published On : 2025-11-20

Eledon Pharmaceuticals (NASDAQ:ELDN – Get Free Report) had its price objective cut by equities researchers at Guggenheim from $9.00 to $8.00 in a research note issued on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the stock. Guggenheim’s price objective indicates a potential upside of 416.13% from the company’s previous close. Several other […]

#General

General

Guggenheim Issues Pessimistic Forecast for Inventiva (NASDAQ:IVA) Stock Price

Published On : 2025-11-20

Inventiva (NASDAQ:IVA – Get Free Report) had its price target reduced by Guggenheim from $13.00 to $11.00 in a report released on Tuesday,Benzinga reports. The firm currently has a “buy” rating on the stock. Guggenheim’s price target indicates a potential upside of 166.34% from the company’s previous close. Several other research firms have also recently […]

#General

General

Halozyme Therapeutics (NASDAQ:HALO) Stock Price Expected to Rise, The Goldman Sachs Group Analyst Says

Published On : 2025-11-20

Halozyme Therapeutics (NASDAQ:HALO – Get Free Report) had its target price boosted by The Goldman Sachs Group from $54.00 to $56.00 in a research report issued on Tuesday,Benzinga reports. The brokerage presently has a “neutral” rating on the biopharmaceutical company’s stock. The Goldman Sachs Group’s price objective points to a potential downside of 20.28% from […]

#General

General

Hovde Group Initiates Coverage on Costco Wholesale (NASDAQ:COST)

Published On : 2025-11-20

Equities research analysts at Hovde Group began coverage on shares of Costco Wholesale (NASDAQ:COST – Get Free Report) in a research note issued on Tuesday,MarketScreener reports. The brokerage set a “market perform” rating and a $16.00 price target on the retailer’s stock. Hovde Group’s target price would indicate a potential downside of 98.20% from the […]

#General

Sports

How to play Chisa in Wuthering Waves

Published On : 2025-11-20

Playing Chisa in Wuthering Waves is quite straightforward.

#Sports

General

Immatics (NASDAQ:IMTX) Stock Price Expected to Rise, Guggenheim Analyst Says

Published On : 2025-11-20

Immatics (NASDAQ:IMTX – Get Free Report) had its price objective raised by equities research analysts at Guggenheim from $16.00 to $19.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the stock. Guggenheim’s price target points to a potential upside of 83.93% from the […]

#General

Sports

Is Morgan Wallen at the CMAs 2025? Fans express outrage over the singer not winning any awards despite being nominated

Published On : 2025-11-20

Morgan Wallen reportedly failed to win an award at the 59th Annual Country Music Association Awards despite being nominated in three of the top categories: Album of the Year (for his album I’m the Pro

#Sports

General

Janux Therapeutics (NASDAQ:JANX) Coverage Initiated at Wolfe Research

Published On : 2025-11-20

Equities researchers at Wolfe Research started coverage on shares of Janux Therapeutics (NASDAQ:JANX – Get Free Report) in a note issued to investors on Tuesday, Marketbeat.com reports. The brokerage set a “peer perform” rating on the stock. Other research analysts have also issued research reports about the company. Guggenheim began coverage on Janux Therapeutics in […]

#General